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Abstract
Purpose—To characterize the potential of newborn retinal stem cells (RSCs) isolated from the
radial glia population to integrate the retina, this study was conducted to investigate the fate of in
vitro expanded RSCs transplanted into retinas devoid of photoreceptors (adult rd1 and old VPP mice
and rhodopsin-mutated transgenic mice) or partially degenerated retina (adult VPP mice) retinas.
Methods—Populations of RSCs and progenitor cells were isolated either from DBA2J newborn
mice and labeled with the red lipophilic fluorescent dye (PKH26) or from GFP (green fluorescent
protein) transgenic mice. After expansion in EGF+FGF2 (epidermal growth factor+fibroblast growth
factor), cells were transplanted intravitreally or subretinally into the eyes of adult wild-type,
transgenic mice undergoing slow (VPP strain) or rapid (rd1 strain) retinal degeneration.
Results—Only limited migration and differentiation of the cells were observed in normal mice
injected subretinally or in VPP and rd1 mice injected intravitreally. After subretinal injection in old
VPP mice, transplanted cells massively migrated into the ganglion cell layer and, at 1 and 4 weeks
after injection, harbored neuronal and glial markers expressed locally, such as β-tubulin-III, NeuN,
Brn3b, or glial fibrillary acidic protein (GFAP), with a marked preference for the glial phenotype.
In adult VPP retinas, the grafted cells behaved similarly. Few grafted cells stayed in the degenerating
outer nuclear layer (ONL). These cells were, in rare cases, positive for rhodopsin or recoverin,
markers specific for photoreceptors and some bipolar cells.
Conclusions—These results show that the grafted cells preferentially integrate into the GCL and
IPL and express ganglion cell or glial markers, thus exhibiting migratory and differentiation
preferences when injected subretinally. It also appears that the retina, whether partially degenerated
or already degenerated, does not provide signals to induce massive differentiation of RSCs into
photoreceptors. This observation suggests that a predifferentiation of RSCs into photoreceptors
before transplantation may be necessary to obtain graft integration in the ONL.
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Neuroretinal degenerative diseases such as retinitis pigmentosa and age-related macular
degeneration are the major causes of blindness in the Western world. Such disorders are the
consequence of various intrinsic and extrinsic factors (reviewed in Ref. 1) and generally result
in the complete loss of visual function as a consequence of photoreceptor degeneration.
Cellular transplantation has been proposed as a potential treatment of these retinal-degenerative
diseases (reviewed in Ref. 2). The donor cells and the host recipient are two major key aspects
of the procedure. Various injection studies have been undertaken with different cellular types
to replace lost cells, but have not so far been unequivocal. Hippocampal,3–5 embryonic (ES),
6 and bone marrow 7 stem cells have been tested in models of retinal degenerative disorders.
These cells show high migratory and differentiation capacity, as they can differentiate into
neurons, astrocytes, and oligodendrocytes. Of note, cells derived from ES cells can form retinal
neurons.8,9
Conversely, the use of retinal stem/progenitor cells in suspension or as neurospheres exhibit
poor migration but are successful in expressing retina-specific markers after transplantation.
10–12 Moreover, we recently showed that adult human retinal stem cells (RSCs) can generate
retinal cells when grafted into a developing retina.13 It has been described that cell integration
occurs in the adult rodent eye primarily in mechanically3 or genetically injured retinas14 but
not in the normal adult one.14 The types of the retinas investigated can be subdivided into two
groups: partially degenerated retinas and fully degenerated retinas. From a clinical point of
view, the latter is of prime importance to investigate,15–18 to assess whether these retinas,
completely devoid of any photoreceptors, would allow RSC incorporation.
To address whether newborn mouse RSCs would populate a normal or diseased retina, we used
characterized cells contained in the radial glia cell population, showing a high proliferation
potential that generates RSCs and progenitor and precursor cells in culture (previously
described in Ref. 19). These cells are contained in the RC2-positive population (radial glia
marker), they express transcription factors usually found in radial glia (Mash1, Pax6), and ~3%
to 5% of the cultured cells meet the criteria of stem cells: high capacity for expansion,
maintenance of an undifferentiated state, and multipotency demonstrated by clonal analysis.
19 These cells are different from the retinal stem cells and progenitor cells previously isolated.
Of note, another group has also isolated central nervous system (CNS) stem cells in the radial
glia cell population of different regions of the mouse brain.20 Moreover, these RSCs can give
rise in vitro to cells committed to a retinal neuron fate including photoreceptors and retinal
ganglion cells.19,21 In the current study, we transplanted them intravitreally into the rapidly
degenerating eyes of rd1 mice or into slow-degenerating eyes of VPP transgenic mice,22 as
Young et al.5 showed a widespread incorporation of adult rat hippocampal progenitor cells
into the retina of dystrophic rats when injected intravitreally. As results in the intravitreal
transplantation were not satisfying, we transplanted the RSCs subretinally, to bring the cells
into the vicinity of the remaining inner nuclear layer (INL). For this purpose, VPP mice received
subretinal transplantation and wild-type animals were used to assess the feasibility and
reproducibility of the subretinal injection. We showed that RSCs retain the capacity to
differentiate into retinal cells, either at the morphologic level or both morphologically and at
the level of protein expression, in certain layers of the retina (GCL, INL) although the cells
failed to differentiate toward the photoreceptor fate, except in rare cases of partially
degenerated retinas. Depending on the model and grafting procedure used, the cells extensively
migrated toward the innermost layers of the retina (i.e., the GCL, where some cells expressed
RGC markers). This demonstrates that RSCs can respond to cues in the natural
microenvironment of a diseased retina, but newly generated photoreceptors would be needed
to support photoreceptor replacement.
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Materials and Methods
Animals
Animals were handled according to the guidelines on care and use of experimental animals set
by the cantonal veterinary of Vaud and the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research. Donor strains were DBA2J mice (The Jackson Laboratory,
Bar Harbor ME) and eGFP-3′ UTR mice (gift from Masaru Okabe, Osaka University). C57Bl/
6J (The Jackson Laboratory), VPP transgenic mice,22 and FVB/NJ rd1 mutant mice (gift from
Marten van Lohuizen, The Netherlands Cancer Institute, Amsterdam) were used as recipient
animals in our experiments and maintained at 21°C with a dark–light cycle of 12 hours and
fed ad libitum with standard laboratory food and water. eGFP-3′UTR mice contain an enhanced
green fluorescent protein (eGFP).23 FVB/NJ inbred mice are homozygous for the Pde6brd1
allele (rd1 mutation) located in exon 7 of the rod cGMP-phosphodiesterase-β, which causes
an early and severe onset of retinal degeneration.24 VPP mice are transgenic mice heterozygous
for a mutated form of the rhodopsin gene. The VPP transgene consists of three amino acid
substitutions near the N terminus of rhodopsin, Val-20→Gly (V20G), Pro-23→His (P23H)
and Pro-27→Leu (P27L) and causes slow photoreceptor degeneration.22 A total of 66 animals
received cellular transplants in one or both eyes. Grafted cells were found in each of the grafted
eyes, and no graft recipient died. The distribution of the animals in the different experimental
groups is summarized in Table 1.
Preparation of RSCs
RSCs were isolated either from the retina of DBA2J or eGFP-3′UTR newborn mice (between
P0 and P2) as we previously described.19 In brief, the radial glia population was selected by
medium condition, plastic, and cell density used. The eyes were dissected and the optic nerve,
the retinal pigmented epithelium, as well as the central retina were discarded. The tissue was
then digested 10 minutes in an enzyme solution containing Mg2+ (3.2 mM MgCl2) and low
Ca2+ (0.1 mM CaCl2), 1.33 mg/mL trypsin, 0.67 mg/mL hyaluronidase, and 0.2 mg/mL
kynurenic acid (all products were obtained from Sigma-Aldrich, St. Louis, MO), then triturated
with a fire-polished pipette and centrifuged at 1800 rpm. The pellet was resuspended in a serum-
free medium25 containing 20 ng/mL EGF and 20 ng/mL basic FGF-2 (Peprotech, Rocky Hill,
NJ). The cells were plated in a 75-cm2 flask (Nunclon, Naperville, IL) at a density of 3 or 5 ×
105 cells/mL. Cells were trypsinized when they reached 100% confluence and were either
expanded or harvested for transplantation. Because RSCs retain a robust capacity to
differentiate into retinal neurons from early to late cell passages,21 we used cells harvested at
passages 4 to 20. Before transplantation, RSCs from DBA2J were labeled with PKH26 (Sigma-
Aldrich) a lipophilic red dye, at a concentration of 2 μM and washed with PBS or HBSS (Sigma-
Aldrich). Stained cells or GFP-expressing cells were counted with a hemocytometer and the
suspension to be transplanted was diluted to the appropriate cell density, 50,000 cells/μL. We
used mainly PKH26-labeled cells, because they show almost no cell death after transplantation.
We spent much time trying to optimize the handling of GFP-expressing cells to prevent cell
aggregation resulting in massive cell death after the passage of the needle. Indeed, after
dissociation the cells showed a pronounced tendency to stick to each other, rapidly forming
clusters when concentrated, thus most of the results were obtained with PKH26-labeled cells.
Transplantation Procedure
Surgical procedures were performed under volatile anesthesia (Isoflurane; Baxter, Deerfield,
IL). In addition, tetracaine (Tetracaine 1% SDU Faure; Novartis, Basel, Switzerland) was
applied on the surface of the eye as a local anesthesia. A small area of the surface of the sclera
was removed in the superior half of the eye, and a 23-gauge needle (BD Biosciences, Franklin
Lakes, NJ) was used to open the choroid gently. A 5-μL syringe (Hamilton, Reno, NV) with
a 34-gauge needle was used to inject 1.5 μL of cell suspension (~75,000 cells) slowly, into the
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subretinal space (SS) or the vitreous. Control retinas were of three types: noninjected eyes,
sham surgery, or dead cell injections. Sham surgery was performed by injection of PBS or
HBSS, depending on the last wash of the cell suspension, whereas dead cells were obtained
by successive immersions of the cell suspensions in liquid nitrogen before grafting.
Tissue Preparation
Animals were killed by cervical dislocation at different time points after transplantation. Eyes
were removed and fixed in a 4% paraformaldehyde solution for at least 1 hour and then
transferred into 25% sucrose in PBS for at least 2 hours before cryosectioning. Retinal sections
(14 μm) were mounted on APTES (3-aminopropyltriethoxysilane)-treated slides and stored at
room temperature until further processing.
Immunohistochemical Analysis
Sections were blocked in PBS containing 10% normal goat serum and 0.3% Triton for 1 hour
at room temperature and incubated with primary antibodies overnight at 4°C. Primary
antibodies used for immunohistochemical analysis included mouse monoclonal anti-neuronal
nuclei (NeuN, 1:100; Chemicon, Temecula, CA); mouse monoclonal anti-β-tubulin isotype III
(1:1000; Sigma-Aldrich); rabbit polyclonal anti-Brn3b (1:500; gift from Eric E. Turner,
University of California, San Diego); rabbit polyclonal anti-recoverin (1:1000; Chemicon);
rabbit polyclonal anti-glial fibrillary acidic protein (GFAP; 1:400; Dako, Carpinteria, CA).
After incubation with the primary antibody, sections were successively washed in PBS,
incubated with a secondary antibody for 1 hour at room temperature (goat anti-mouse or goat
anti-rabbit conjugated to FITC [1:100] or Cy3 [1:1000] from Jackson ImmunoResearch, West
Grove, PA), washed with PBS and nuclei were counter-stained with DAPI (4′,6-diamidino-2-
phenylindole, dilactate; Invitrogen-Molecular Probes, Eugene, OR). Immunofluorescence was
observed with an epifluorescence microscope (BX60; Olympus, Tokyo, Japan) and a confocal
microscope (LSM 510 Meta; Carl Zeiss Meditec, Dublin, CA).
Cell Survival Analysis
Cells were passed through the syringe needle used for transplantation, and colored with trypan
blue solution 0.4% (Sigma-Aldrich). The percentage of dead cells was then counted on a
hemocytometer.
TUNEL (terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick-end labeling)
was performed on cryostat sections (Dead-End Colorimetric TUNEL System; Promega,
Madison, WI) after the manufacturer’s directions. The number of dead cells was then evaluated
in bright-field images.
Results
Grafted Cell Survival
As the passage through the needle during the graft procedure may be detrimental to the cells,
we evaluated cell death in vitro before and after injection. Cultures from five different mice
were tested with three different 34-gauge needles. We counted 2% of dead cells in the cell
suspension after harvesting and 6% after the passage through the different needles, illustrating
the harmlessness of the procedure for the cells (n = 5; passages 10–20).
We then conducted a TUNEL analysis on six retinas of wild-type C57/Bl6 mice at 1, 2, and 5
days after subretinal injection (short-term survival) to investigate cell death occurring in the
transplanted cells and in the retina. We evaluated both host- and graft-labeled cells, but we did
not observe any increase in cell apoptosis compared with retinas of noninjected wild-type mice
(n = 3 per group; data not shown). Finally, we counted the number of surviving grafted cells
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on bright-field images on C57Bl/6 retinas (n = 3) at 3 months after surgery. We obtained a
mean of 328 ± 104 surviving cells in three different experiments—a long-term cell survival of
0.44% of the number of injected cells in a normal retina.
These results indicate that the procedure and cells used allow a satisfactory cell survival in the
normal retina during the first days after injection and that no tumors are formed, even after
extensive cell passaging.26
Distribution of Retinal Stem Cells Intravitreally Transplanted into Fully Degenerated Retinas
To reveal further the potential of RSCs to differentiate and incorporate into the retina, we
transplanted RSCs into degenerated retinas that had lost all their photoreceptors. In VPP mice,
culture of RSCs (containing also progenitors and precursors) were injected intravitreally at 10
months of age and eyes were collected 1 and 4 weeks after surgery. By 1 week after injection,
grafted cells were observed mainly in a cluster shape that did not infiltrate the neuroretina but
stayed in the vicinity of the GCL along the inner limiting membrane (ILM; Fig. 1A) or near
the lens (data not shown) with only a few isolated cells (n = 3 eyes). In comparison, at 4 weeks
after injection (n = 7 eyes) part of the grafted cells migrated as single scattered elements into
the GCL (Fig. 1B), and a few of them reached the IPL.
To test whether the absence of cell migration in the VPP retina was due to the genetic
background of the mice, we injected the cells into the vitreous of rd/rd mice. The grafted cells
behaved much as they did in VPP mice (Figs. 1C, 1D, n = 6 and 7, respectively, for 1 week
and 4 weeks after transplantation). In addition, RSCs were observed to reach as far as the
anterior chamber (Fig. 1E) and the ciliary body (CB; Fig. 1F).
The contralateral eye of injected animals was used as control, consisting of noninjected eye,
sham surgery, or dead cell–injected retinas. We observed no PKH26- or GFP-expressing cells
in these untreated or sham-injected retinas. In sham-surgery eyes only some retinal detachment
due to the surgical procedure was observed. In the dead cell–injected retinas, we observed no
fluorescent labeling (GFP or PKH26) within the neuroretina, and we mainly found the
remaining PKH26 dye concentrated in the RPE layer. In some cases, we observed a recruitment
of PKH26-positive pigmented cells in various layers of the retina up to the GCL. Four weeks
after injection, the pigmented cells seemed to have cleared out all the fluorescent cell debris,
which can be observed only in rare cases in other layers of the retina in the form of small
isolated fluorescent spots (data not shown). These observations ruled out any occurrence of
dye reabsorption by host cells and appearance of false-positive cells within the retina.
Migration and Differentiation of Retinal Stem Cells in Normal Retinas
As intravitreal injections of RSCs did not show wide incorporation into the host retina that
Young et al.5 demonstrated with the adult rat hippocampal progenitor cells, we investigated
cell behavior after subretinal injections. To evaluate the feasibility and reproducibility of
subretinal injections, we first tested transplantation into normal retinas. We observed that the
grafted cells formed a homogeneous layer between the RPE and the neuroretina (Fig. 2A). The
entire surface of the retina covered by the graft was evaluated by adding the successive graft
sizes measured on all histologic samples multiplied by the width of the tissue cut and the
distance separating each slice. These experiments, performed on six retinas from 1 to 7 days
after transplantation, resulted in a mean size of 10% ± 2.9% of the total size of the retina (Fig.
2B) without any influence of the time elapsed after injection. Migration of the grafted cells
toward the neuroretina was observed only occasionally and seemed to be facilitated by a
mechanical lesion (data not shown). A few of these migrating cells reached the RGC layer.
This migration was occasionally accompanied by differentiation toward the ganglion cell
phenotype, as suggested by the presence of PKH26-positive grafted cells colabeled with NeuN,
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a marker specific for RGCs in the retina (data not shown). In summary, the transplanted RSCs
survived transiently in the SS after the injection, but migration was observed only in regions
showing lesions due to the grafting procedure.
Distribution of Retinal Stem Cells Subretinally Transplanted into Fully Degenerated Retinas
We then tested RSC fate after transplantation into the SS of 10 months old VPP mice, in the
place of the lost photoreceptors. One week after injection (n = 3), most of the donor cells were
in the SS between the remaining INL and the RPE, but contrary to the intravitreal injection
depicting an almost static situation, a good proportion of the cells injected subretinally were
found within all the layers constituting the retina, with some cells having reached the GCL
(Figs. 3A, 3B). It seemed that the donor cells were attracted by the innermost layers of the
retina instead of staying at the place of injection. To verify this, we examined retinas 4 weeks
after injection (n = 7). At this time point, the grafted cells were mainly found in the GCL (Fig.
3C), because of a massive migration toward the inner layers of the retina, with only a few
remaining cells present at the site of injection, or elsewhere in the SS (Fig. 3B). PKH26- and
GFP-positive cells behaved similarly. Moreover, subretinal injections allowed migration of the
RSCs only into the retina and not into other structures of the eye. Taken together, these
observations show that the RSCs have migratory preferences and cannot adopt a photoreceptor
phenotype in our different experimental paradigms (C57Bl/6 normal retina, VPP, or rd1
degenerated retinas). Nevertheless, the architectural organization of the host retina is not
disrupted by the transplantation procedure or cell migration and RSCs can morphologically
incorporate into the retina.
Transplantation and Cell Death
Previous studies have shown that neural progenitors can migrate toward the location of
neuronal degeneration. We investigated whether the VPP retina undergoes cell death in the
ganglion cell layer at 10 months of age and if the injection procedure induces apoptosis. Seven
days after transplantation, we used TUNEL labeling to determine the cell death rate in the
GCL. At this period, cells were still migrating, suggesting that some signals were delivered by
the GCL. These results showed no differences in the number of dying RGCs in fully
degenerated compared with wild-type retinas (data not shown). Surprisingly, the INL
demonstrated a slight increase of TUNEL-positive cells in degenerated compared with wild-
type retinas (data not shown). Few transplanted cells were dying. These data suggest that, in
this case, the site of migration is not directly linked to neuronal degeneration. Concerning the
survival of the transplanted cells, thousands of cells were still present in the degenerated and
the partially degenerated retina 1 month after the injection, showing a good survival in a
diseased retina.
Homotopic Differentiation of RSCs Transplanted into the Degenerated Retina
After the characterization of cell migration and morphology transformation, we investigated
cell fate acquisition in all the cell transplantation paradigms tested. After subretinal injection,
because we observed that several transplanted cells were located in the GCL, the IPL, or the
INL, we investigated whether they had differentiated into cell phenotypes consistent with the
layer they occupied. We observed that transplanted RSCs differentiated along neuronal and
glial phenotypes. In the GCL we observed that several transplanted cells expressed the pan-
neuronal marker β-tubulin-III (Figs. 4A1–A3). To better assess the neuronal phenotype of the
donor cells located in the GCL, we used anti-NeuN and anti-Brn3b antibodies. In the retina,
Brn3b is a transcription factor expressed only by a subpopulation of RGCs27 and NeuN is
expressed only in the RGC layer28 (Figs. 4B1–B3, 4C1–C3, respectively). Strikingly, all
grafted cells positive for these markers were located in the GCL, or in the close vicinity to it
only, indicating that the cells responded to the specific region of the ganglion cell layer. On
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the one hand, this suggests that RSCs expanded in vitro can differentiate toward the RGC
phenotype as we previously observed in vitro.19 On the other hand, RSCs failed to express
recoverin, a specific marker for photoreceptors and rare bipolar cells,29 and calbindin, a
horizontal cell specific marker, despite the fact that some of them had a morphology resembling
this cell type (Figs. 4D1, 4D2). It seemed that in the present transplantation paradigm, the
acquisition of morphologic characteristics occurred before the expression of specific markers.
Indeed, after subretinal injections, we observed grafted cells with a typical bipolar shape (Fig.
4E) located in the INL and possessing two large neurites ending in the two adjacent plexiform
layers. Of interest, we observed in rare cases grafted cells in the SS expressing rhodopsin
(Rho1D4; Figs. 4F1–4F3). This occurred 1 week after injection; such cells were never found
1 month after surgery.
Moreover, in the IPL, normally devoid of any cell bodies, we observed multistratified cells
with dendrites terminating at the two sublaminae of the IPL (data not shown). Nevertheless,
most grafted cells did not express specific neuronal markers but many expressed GFAP, a
specific glial marker (Figs. 5A1, 5A2, 5A3). After intravitreal injections, we observed clusters
of grafted cells labeled by GFAP near the GCL (Fig. 5B), the lens (Fig. 5B), the iris (data not
shown), and the CB (data not shown), regions that are normally devoid of any immunoreactivity
to the GFAP marker. Moreover, the subretinal transplantation was accompanied by increased
glial activity in the region in which grafted cells were located as well as at the injection site
(Fig. 5D) compared with noninjected retinas. These observations clearly indicate that the RSCs
have a marked preference to differentiate along the glial phenotype in this microenvironment.
Distribution and Retinal Phenotypes of RSCs Transplanted into Partially Degenerated
Retinas
Because we concluded that delivered cells did not adopt a photoreceptor fate in the completely
degenerated retina, we wanted to know whether the remaining photoreceptors in the younger
partially degenerated VPP retina could provide support for correct localization and
photoreceptor differentiation of the grafted cells. We injected RSCs in 7-month-old VPP mice
in which three to six rows of photoreceptors were still present (Figs. 6A1, A2, B). Intravitreal
injections gave results almost identical with the older, fully degenerated retina (compare Figs.
6B, 6C to Figs. 1E, 1F; (n = 9). Some differences appeared only after subretinal injections.
Four weeks after transplantation, a few cells had morphologically incorporated into the
remaining ONL. The massive migration that was observed in the fully degenerated retina was
thus slightly less extended in this earlier form of the disease. We also identified grafted cells
in the ONL that expressed recoverin, a specific marker for photoreceptors, but only in very
rare cases (Figs. 6E1–6E3), which suggests that the RSCs may retain the capacity to
differentiate into the photoreceptor lineage, but the ONL was clearly not the principal migratory
target of the RSCs grafted in the partially degenerated VPP retina. Indeed, RSCs, when injected
subretinally, behaved similarly to previous experiments and most of the cells migrated toward
the GCL and acquired a glial phenotype expressing GFAP (see above; Figs. 6D1–6D3).
Discussion
To investigate the ability of the allogeneic retinal stem and progenitor cells derived from the
radial glia to incorporate into the retina, we examined their fate after transplantation within
normal and diseased retinas. Our observations showed that RSCs transplanted into the fully
degenerated retina either stay in the vicinity of the GCL when transplanted into the vitreous or
massively migrate toward the GCL when transplanted subretinally. Moreover, several grafted
cells differentiated into retinal cells in accordance with the cell layer in which they had
integrated. However, they failed to give rise to photoreceptors in a model in which the latter
degenerate.
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After transplantation into the vitreous of two mouse models of retinal degeneration (VPP mice
and rd1 mice), grafted cells were widely distributed in a clusterlike form along the inner
limiting membrane 1 week after transplantation. The lack of migration across the retina
indicated that the ILM may constitute a barrier preventing further migration of the grafted cells
as previously described in other models.6,30 However, after subretinal injections into the
completely degenerated as well as the younger but partially degenerated VPP retinas, massive
migration of the grafted cells was observed toward the GCL. Cells transplanted into the SS—
close to the degenerating photoreceptors—were expected to diffuse laterally and not migrate
to the retinal innermost layers. This extensive migration implies that certain intrinsic or
extrinsic signals act on the grafted cells and that these cells can actually respond to these signals
in a seemingly rapid and active process, as the migration is almost complete 4 weeks after
surgery. This migration potential of RSCs appears to be different from the behavior of the
RPCs tested in other studies,11,12 which remained at the injection site. Radial glia are known
to show a marked mobility during development, with a permanent movement of the cell body
between the surface of the ventricle and the proliferating zone. Moreover, radial glia migrate
to different layers of the brain to generate neurons and astrocytes (reviewed in Ref. 31). It
appears that the RSCs of the radial glia maintained their capacity to migrate even after extensive
amplification in vitro.
In addition, we observed that this migration is accompanied by the sprouting of neurites from
the grafted cells into other layers of the retina, further suggesting the fact that these cells respond
to signals.
Although donor cells massively incorporated into the GCL when transplanted subretinally,
they failed to integrate the ONL and to differentiate along the photoreceptor lineage. Several
hypotheses emerge from these observations. It has been shown that neural progenitors can
migrate toward the location of neuronal degeneration.5,32 In the present study, however, by
the time of the transplantation experiment, the process of degeneration had reached the INL,
but was not followed by incorporation of grafted cells into this layer. It is possible that the
death of INL cells induces a metabolic change in one of their targets, the RGCs. After
reorganization of the retinal cells during the degeneration, the VPP retina may generate signals
to establish new contacts during the degeneration process, as previously observed in the rd1
mice.33,34 Such signals are usually constituted of neurotrophic factors and neurotransmitter
secretion, which allow neurite sprouting, outgrowth, and synaptic remodelling (reviewed in
Ref. 35,36). Similar signals are also required during cell differentiation and maturation. As a
consequence, it is possible that the transplanted RSCs respond to these signals and differentiate
into neurons and glia in the RGC. In fact, the major differentiation into RGCs after
transplantation was observed in the fully degenerated retina and not during degeneration.
Finally, during the expansion period, the EGF used in our culture medium may prime the cells
preferentially toward the RGC phenotype.19 Indeed, we have shown that EGF in the presence
of laminin is sufficient to commit RSCs to the RGC fate. This priming may occur during the
expansion period in vitro and, in the natural microenvironment, some cells may respond to
other environmental cues (such as laminin) to enhance RGC differentiation. Transplantation
studies have shown very different results in animal models of retinal degeneration. It has been
shown that hippocampus-derived neural progenitor cells transplanted into the retina can
differentiate into neurons and glial cells and incorporate into the developing13,37–39 and adult
retina if it is mechanically or genetically injured.3,14,40 However, these cells constantly failed
to undergo differentiation into specific retinal neurons.4,5,32,41–43 Conversely, retinal cells
successfully differentiated into retinal neurons and glia, but were not accompanied by extended
migration into the retina.10–12 In the present study, subretinally transplanted cells showed a
robust migration into the GCL accompanied by a moderate differentiation toward the ganglion
cell phenotype. We have shown that stem cells isolated at a late stage of neurogenesis can give
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rise in vitro to early born neurons.19 This indicates that the state of the RSCs is permissive for
differentiation into RGCs and may suggest that they will also be able to give rise to the other
retinal cells if appropriate stimulations are found, as we previously observed in vitro, for the
generation of RSCs committed to the photoreceptor fate.21 This notion is further supported by
the acquisition at the morphologic level of phenotypes resembling bipolar cells and horizontal
cells located in the correct retinal compartment.
However, RSCs have a marked preference for the glial phenotype. Throughout the whole retina,
Müller cells are the main glial cell type present, whereas astrocytes are exclusively found in
the GCL. Activation of the glial cells by surgical procedures has been largely demonstrated
(reviewed in Ref. 44). It is thus possible that after transplantation the grafted cells respond
preferentially to signals that induce glial activation instead of signals that promote neuronal
differentiation. We have recently shown that during the expansion period in culture medium
containing EGF and FGF-2, the cells express markers not only present in stem cells such as
nestin45 and Bmi146–49 but also RC2,50 Mash1, and Pax6, factors that have been shown to
be expressed by radial glia.19,47,51 RSCs injected into the retina may thus retain glial
characteristics and undergo glial differentiation, especially in the absence of signals driving
the cells toward the neuronal lineage. On the opposite side, RSCs may give rise to glial cells
in response to signals promoting glial differentiation present in the microenvironment, as has
been suggested with NSCs transplanted into the CNS due to reactive gliosis after injury.
Lundberg et al. and others52–54 have shown that stem/progenitor cells transplanted into the
brain preferentially acquire glial characteristics.
Finally, in rare cases we obtained expression of the recoverin and rhodopsin markers in grafted
cells. Such expression is not satisfactorily reliable because of the scattered occurrence of this
observation but clearly indicates that RSCs can indeed undergo differentiation in vivo into
another retinal fate than RGCs. It is thus important to determine why, in our experimental
paradigm, RSCs failed to repopulate the ONL and what can be done to achieve photoreceptor
differentiation and integration in vivo.
First, cell contact between grafted cells and remaining photoreceptors seems insufficient to
drive photoreceptor differentiation. Only scattered cells were found in the ONL after
transplantation into partially degenerated retinas and expression of recoverin and rhodopsin
was sparse. In our hands, in vitro culture conditions allowed the differentiation of numerous
cells into the photoreceptor cell type, expressing several photoreceptor proteins or genes.21
This shows that the RSCs have the ability to undergo photoreceptor differentiation, but that
the degenerated retina of the VPP mice do not provide signals supporting differentiation of this
kind.
Second, during degeneration, remaining host photoreceptors may release apoptotic signals, or
stop releasing survival factors,55 which could be harmful for RSCs. This is a potential
explanation for the small number of donor cells that survived in the ONL. However, because
donor cells migrated and did not die, this hypothesis is unlikely.
Our results contrast with those describing that RPCs are capable of generating cells expressing
photoreceptor markers after transplantation. Of note, it seems that fetal RPCs have a better
capacity to generate a large number of cells committed to the photoreceptor pathway than
newborn RPCs11 and RSCs, respectively. In fact, newborn RPCs showed a potential to generate
photoreceptor-like cells in a degenerating retina, but to a lesser extent than fetal RPCs.
However, the proliferation and differentiation potentials of the fetal RPCs are not known, and
it is difficult to evaluate their primitiveness. Moreover, the cell type, the animal model, or the
culture conditions used in these studies are all different and it is difficult to identify what favors
the appearance of the photoreceptor phenotype in vivo.
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In conclusion, we have shown that RSCs can differentiate into retinal phenotypes and are able
to migrate extensively toward inner structures of the retina responding to cues not yet
determined. Also, to obtain robust differentiation or integration into the ONL, it seems likely
that the grafted cells must be driven, before transplantation, through the neuronal lineage
instead of the glial one. These findings suggest that (1) more specialized cells may be needed
to integrate the ONL, like restricted progenitors primed to become photoreceptors, or fully
differentiated photoreceptors. Indeed, cells derived from mouse ES cells previously induced
toward the neuronal lineage in vitro were able to incorporate the retina and expressed retinal
cell-specific markers,8,9 whereas transplantation of mouse ES cells is accompanied by tumor
formation.56 (2) An artificial substrate to enhance cell survival or cell differentiation could be
useful.57
Another possibility is to couple the injection of the cell suspension with growth or proneural
factors or to engineer the cells genetically to commit them to the desired fate.58
Furthermore, we have shown that in our transplantation model, RSCs can incorporate into a
diseased retina when subretinally transplanted but exhibit a migration and a differentiation
preference. Last, the acquisition of the retinal phenotype, either morphologically or at the level
of protein expression, seems to be region-specific for the ganglion cell layer and indicates that
the cells respond to specific signals suggesting that manipulation of these signals may help to
replace lost cells at the right place.
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Figure 1.
Cell localization after transplantation in retinas devoid of photoreceptors showed only slight
migration when injected intravitreally in VPP as well as in rd1 mice. (A) By 1 week after
injection, RSCs intravitreally injected into the VPP mouse retina formed elongated clusters
located in close proximity to the GCL but not within. (B) By 4 weeks after surgical intervention,
some grafted cells had migrated within the GCL. In the rd1 mice, transplanted cells showed
similar localization equally close to the GCL during the week after injection (C) and slight
migration within it 4 weeks after transplantation (D). Moreover, intravitreal injection allowed
the cells to migrate into various structures of the rd1 eye such as the iris (E) and the CB (F),
which is not the case with subretinal injections (not shown).
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Figure 2.
Assessment of the subretinal injection in the normal retina. The size of the graft is expressed
as a percentage of the total surface of the retina in six retinas from 0 to 7 days after injection
(A). Subretinal injection of RSCs into the eye of C57Bl/6 mice shows that the cells labeled
with the PKH26 were restricted to the SS and were not scattered in other layers of the retina 2
days after the surgery (B). Scale bar, 50 μm.
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Figure 3.
RSCs massively migrated toward the innermost layer of the retina after subretinal injection
into fully degenerated VPP retinas. Compared with the poor migration of intravitreally injected
cells (Fig. 1), subretinal injections exhibited a massive migration of the RSCs toward the GCL
of VPP retinas. This migration was already observable by 1 week after surgery, with cells
present in the subretinal space (the site of injection) as well as in all the other layers of the
retina up to the GCL with GFP-expressing RSCs (A) and PKH26-labeled RSCs (B). The
migration into the GCL was completed by 4 weeks after injection (C). Scale bars: (A, B) 50
μm; (C) 100 μm.
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Figure 4.
RSCs expressed neuronal and neuroretinal markers after transplantation in a fully degenerated
retina. (A1, B1, C1, F1) Fluorescence images of degenerated retinal sections showing DAPI
staining (blue) of the nuclei and PKH26-labeled RSCs (red) within the host GCL; (A2, B2,
C2, F2) grafted cells and host retina labeled with specific antibodies revealed by secondary
antibodies coupled to FITC (green) and nuclei labeled with DAPI; (A3, B3, C3, F3) merged
images showing colocalization of the PKH26 (red) with the antibody labeling (green) and the
DAPI staining (blue). RSCs injected subretinally incorporated into the GCL and expressed the
early neuronal marker β-tubulin-III (A). The RSCs that incorporated into the GCL expressed
Brn3b (B) a marker for mature ganglion cells (inset: positive control for Brn3b labeling, note
that Brn3b labels a subpopulation of RGC). Integrated RSCs also express NeuN (C) a specific
marker for ganglion cell lineage in the retina as shown in confocal images (C). Colocalization
of these antibodies (Brn3b and NeuN) and the PKH26 among the host retina was observed
exclusively in the GCL, denoting a region of specific immunoreactivity. Insets: higher
magnification of the area defined by the arrows (D, E). Fluorescence images of GFP-
expressing RSCs subretinally injected and exhibiting morphologies resembling horizontal cells
(D1, D2, arrowheads) close to calbindin-positive cells (a specific marker for horizontal cells,
D2, red, arrow) but negative for the latter, even if exhibiting a similar morphology, and with
bipolar cells (E, arrow) correctly located and oriented in the INL. Occasionally, RSCs that did
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not migrate toward the GCL but stayed close to the INL, where few remaining photoreceptors
were located, expressed rhodopsin, a specific marker for photoreceptors (F, confocal image).
Scale bar: (A, B) 25 μm; (C, F) 30 μm; (D) 10 μm; (E) 100 μm.
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Figure 5.
Glial cell differentiation after transplantation. (A1) Fluorescence images of retinal sections
showing PKH26-labeled RSCs (red) within the host degenerated retina and DAPI staining
(blue) of the nuclei; (A2) grafted cells and host retina labeled with anti-GFAP revealed by a
secondary antibody coupled to FITC (green) and nuclei labeled with DAPI; (A3) merged image
showing colocalization of the PKH26 (red) with the antibody labeling (green) and the DAPI
staining (blue). Colocalization depicts a grafted cell positive for the glial marker GFAP within
the host GCL after subretinal injection (A). The preference for the glial phenotype is supported
by the colocalization of PKH26 and GFAP in cells integrated after intravitreal injections. This
preference is further supported by the high degree of GFAP expression (green) by grafted
(red) cells that have migrated close to the lens (B) after intravitreal delivery of RSCs.
Endogenous glia revealed by GFAP immunostaining (green) in a control retina, labels only
end feet of Müller cells and the astrocytes contained in the GCL (C). In comparison, in
transplanted retina, 4 weeks after surgery, extensive gliosis related to increased GFAP labeling
(green) is observed (D) in the site of injection (arrowheads) up to the site where grafted cells
(red) incorporate (✱). DAPI staining to visualize nuclei was performed on each section
(blue). Scale bar, (A) 25 μm; (B) 50 μm; (C, D) 100 μm.
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Figure 6.
RSCs transplanted to partially degenerated retina (7-month-old VPP) did not integrate better
into the ONL and showed a higher tendency to acquire glial characteristics than cells
transplanted into fully degenerated retina. The ONL of 7-month retinas presented one to six
rows of photoreceptors, illustrating the heterogeneity of the degeneration as shown in retinal
sections from the same retinal area of two animals of the same age (A1, A2). Intravitreal
injection in the partially degenerated retina was rigorously similar to the fully degenerated
retina by 1 week and 4 weeks after injection (B, C, respectively). After subretinal injections,
grafted RSCs had massively migrated toward the GCL and expressed the glial marker, GFAP
(D1, D2, D3). Indeed, GFP expressing RSCs (green, D1) and GFAP immunostaining (red,
D2) colocalized, shown in a merged image (orange, D3). Thus, RSCs transplanted into the
partially degenerated 7-month-old VPP mouse retina behaved almost like those in their
counterparts at 10 months of age. Nevertheless, 4 weeks after transplantation, some subretinally
injected RSCs stayed in the remaining ONL (E1, arrowhead) and in rare cases express the
recoverin marker (E2, E3, arrowhead). DAPI staining to visualize nuclei was performed on
each section. Scale bar: (A) 25 μm; (B–E) 50 μm.
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Table 1
Distribution of the Animals in the Different Experimental Groups
Mouse Strain Age at Injection Time Type of Injection Time after Injection n
C57B1/6 Adult Subretinal 0–30 d 28
rd1 mouse strain 1 mo Intravitreal 1 wk 6
1 mo 7
1 mo Subretinal 1 wk —
1 mo —
VPP mouse strain 10 mo Intravitreal 1 wk 3
1 mo 7
10 mo Subretinal 1 wk 3
1 mo 7
7 mo Intravitreal 1 wk 2
1 mo 7
7 mo Subretinal 1 wk 3
1 mo 3
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